Eli Lilly and Co (NYSE:LLY)
| 583.86 Delayed Data As of 4:00pm ET |  -7.18 / -1.21%Today’s Change | 309.20 Today|||52-Week Range 629.97 | +59.59% Year-to-Date |
Latest LLY News | Press Releases
Today’s Trading
| Previous close | 591.04 |
| Today’s open | 591.91 |
| Day’s range | 583.17 - 601.55 |
| Volume | 3,638,565 |
| Average volume (3 months) | 3,174,977 |
| Market cap | $561.6B |
Data as of 4:00pm ET, 12/01/2023
Growth & Valuation
| Earnings growth (last year) | +12.53% |
| Earnings growth (this year) | +9.51% |
| Earnings growth (next 5 years) | +27.44% |
| Revenue growth (last year) | +0.79% |
| P/E ratio | 105.8 |
| Price/Sales | 11.60 |
| Price/Book | 52.78 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| JNJJohnson & Johnson | +3.73 | +2.41% |
| NVONovo Nordisk | -1.45 | -1.42% |
| MRKMerck | +0.96 | +0.94% |
| ABBVAbbVie | +1.01 | +0.71% |
Data as of 4:00pm ET, 12/01/2023
Financials
| Next reporting date | February 6, 2024 |
| EPS forecast (this quarter) | $2.78 |
| Annual revenue (last year) | $28.5B |
| Annual profit (last year) | $6.2B |
| Net profit margin | 21.88% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters --, -- |
Forecasts
